老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Cellectar Biosciences Inc.

4.88
-0.0500-1.01%
盤後：4.78-0.1000-2.05%19:58 EDT
成交量：6.17萬
成交額：30.40萬
市值：1,394.22萬
市盈率：-0.21
高：5.05
開：4.96
低：4.80
收：4.93
資料載入中...
總覽公司新聞公告
2020/06/11

重要事件披露

8-K - Current report
2020/06/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/05

重要事件披露

8-K - Current report
2020/06/03

重要事件披露

8-K - Current report
2020/06/01

SEC問詢函

CORRESP [Cover] - Correspondence
2020/06/01

重要事件披露

8-K - Current report
2020/05/26

重要事件披露

8-K - Current report
2020/05/20

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/05/20

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/05/14

重要事件披露

8-K - Current report
2020/05/08

招股説明書

General form for registration of securities under the Securities Act of 1933
2020/05/07

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/05/07

重要事件披露

Current report, items 2.02 and 9.01
2020/03/09

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/09

重要事件披露

Current report, items 2.02 and 9.01
2020/02/20

重要事件披露

Current report, items 7.01 and 9.01
2020/02/19

重要事件披露

Current report, items 7.01 and 9.01
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
更多